HSDT
Helius Medical Technologies Inc Class A
2.70$
+0.8%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1,714.7% | -1,517.9% | -2,223.0% | -1,588.5% | -5,433.3% | -1,564.5% | -7,216.3% | -6,411.6% | -580.2% | -118.2% | -133.4% | -470.8% | -223.2% | |
| 38.5% | 15.7% | 11.9% | 8.8% | 31.4% | 7.9% | 16.3% | 20.9% | 95.1% | – | – | – | – | |
| 281.8% | 299.3% | 297.0% | 201.1% | 2,602.0% | 281.6% | 1,269.4% | 951.2% | 67.9% | 148.2% | 2.5% | 2.5% | 69.4% | |
| 16.8% | -214.9% | -28.9% | -45.1% | -288.2% | 171.1% | -377.6% | 174.4% | 15.8% | -6.1% | 6.2% | -31.7% | -6.5% | |
| 4.2% | 2.2% | 3.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| -4.2% | -2.2% | -3.7% | – | – | – | – | – | -38,362.0% | -3,044.2% | 151.0% | 216.7% | -3,442.6% | |
| – | – | 0.0% | – | – | – | 0.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | 0.0% | 0.0% | – | – | -97.3% | -92.3% | – | |
| – | – | – | – | 0.0% | – | – | – | 0.0% | 0.0% | – | – | – | |
| 318.2% | 464.2% | 1,083.7% | 3,098.9% | -292.2% | 0.0% | 7,259.2% | 17,967.4% | 55,867.9% | 928.8% | -97.3% | 224.5% | 3,645.6% | |
| -1,400.7% | -1,055.2% | -1,143.7% | 1,510.4% | -5,723.5% | -1,565.8% | 42.9% | 11,555.8% | 16,925.8% | -2,233.5% | -79.7% | -29.6% | -20.1% | |
| -1,718.9% | -1,520.1% | -2,226.7% | -1,588.5% | -5,433.3% | -1,564.5% | -7,216.3% | -6,411.6% | -580.2% | -118.2% | -133.4% | -470.8% | -223.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.